Login to Your Account



End of 'Ridiculous Circle'

First Gene Therapy Glybera (Finally) Gets EMA Approval

By Nuala Moran
Staff Writer

Wednesday, July 25, 2012

LONDON – The first gene therapy to be approved in a Western regulated market finally made it over the finishing line on Thursday when the European Medicines Agency (EMA) gave the nod to Glybera after considering the treatment for lipoprotein lipase deficiency (LPL) for the fourth time.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription